Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Oruka Therapeutics Stock News

ORKANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$12.36

0.000.00%

After Hours: Mar 24, 4:00 PM EDT

Oruka Therapeutics (ORKA) Forecast

News

Earnings Oruka Therapeutics (ORKA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Oruka Therapeutics Stock News | NASDAQ:ORKA | Benzinga

Get the latest news on Oruka Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Oruka Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, March 07, 2025

Oruka Therapeutics Announces Preclinical Data...
Benzinga Newsdesk

Thursday, March 06, 2025

Oruka Therapeutics Q4 2024 GAAP EPS $(0.49) B...
Benzinga Newsdesk

Friday, February 07, 2025

HC Wainwright & Co. Reiterates Buy on Oruka T...
Benzinga Newsdesk

Wednesday, February 05, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights

Tuesday, February 04, 2025

This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Avi Kapoor
Wolfe Research Initiates Coverage On Oruka Th...
Benzinga Newsdesk
PayPal, Estée Lauder, UBS And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Wednesday, January 15, 2025

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Why Vision Marine Technologies Shares Are Trading Higher By 68%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Friday, December 20, 2024

HC Wainwright & Co. Reiterates Buy on Oruka T...
Benzinga Newsdesk

Thursday, December 19, 2024

Oruka Therapeutics Has Initiated Dosing Of He...
Benzinga Newsdesk

Wednesday, December 18, 2024

Oruka Therapeutics Announced That It Is Expec...
Benzinga Newsdesk

Monday, November 25, 2024

HC Wainwright & Co. Reiterates Buy on Oruka T...
Benzinga Newsdesk

Thursday, November 14, 2024

Oruka Therapeutics shares are trading lower a...
Benzinga Newsdesk

Wednesday, November 13, 2024

Oruka Therapeutics Q3 2024 GAAP EPS $(1.46) M...
Benzinga Newsdesk

Thursday, October 31, 2024

HC Wainwright & Co. Reiterates Buy on Oruka T...
Benzinga Newsdesk

Friday, October 11, 2024

Stifel Initiates Coverage On Oruka Therapeuti...
Benzinga Newsdesk

Tuesday, October 08, 2024

Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Monday, October 07, 2024

HC Wainwright & Co. Initiates Coverage On Oru...
Benzinga Newsdesk

Wednesday, September 25, 2024

Oruka Therapeutics Announced New Preclinical ...
Benzinga Newsdesk

Tuesday, September 17, 2024

Leerink Partners Initiates Coverage On Oruka ...
Benzinga Newsdesk
Leerink Swann Initiates Coverage On Oruka The...
Benzinga Newsdesk

Monday, September 16, 2024

LifeSci Capital Initiates Coverage On Oruka T...
Benzinga Newsdesk
TD Cowen Initiates Coverage On Oruka Therapeu...
Benzinga Newsdesk

Friday, September 13, 2024

Jefferies Initiates Coverage On Oruka Therape...
Benzinga Newsdesk

Thursday, September 12, 2024

Oruka Therapeutics Announced A Private Invest...
Benzinga Newsdesk

Wednesday, September 04, 2024

Oruka Therapeutics shares are trading higher ...
Benzinga Newsdesk
Wedbush Initiates Coverage On Oruka Therapeut...
Benzinga Newsdesk

Tuesday, September 03, 2024

Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Oruka Therapeutics Completes Merger with ARCA...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved